Featured Asia Pacific Experience
AssetMark to Be Acquired by Huatai Securities
Willkie represented AssetMark, Inc. in its agreement to be purchased by Huatai Securities from Aquiline Capital Partners and Genstar Capital.
WuXi PharmaTech Enters Into $3.3 Billion LBO
Willkie represented the Special Committee of the Board of Directors of WuXi PharmaTech Inc. in its $3.3 billion management-led leveraged buyout, one of the largest going private transactions of a Chinese-based, U.S. listed company.
Dai-ichi Life in $5.7 Billion Acquisition of Protective Life
Willkie represented Tokyo-based Dai-ichi Life Insurance Company, Limited in its $5.7 billion acquisition of Protective Life Corporation. Dai-ichi Life, the second largest private life insurance company in Japan, is one of the top 20 global life insurers, operating throughout Japan, Australia, Vietnam, Indonesia, India and Thailand.
Cornerstone Investor in Largest-Ever IPO in Thailand
Willkie advised a cornerstone investor in BTS Group Holdings PCL's $2.13 billion initial public offering, the largest-ever IPO in Thailand.
Sepracor in $2.6 Billion Acquisition by Dainippon Sumitomo Pharma
Japanese pharmaceutical manufacturer Dainippon Sumitomo Pharma Co., Ltd. (DSP) acquired Willkie client Sepracor Inc., a specialty drug maker, for approximately $2.6 billion.
iParadigms in $752 Million Sale
GIC, Singapore's sovereign wealth fund, and Insight Venture partners agreed to acquire Willkie client iParadigms, a California-based anti-plagiarism software company, from majority owner Warburg Pincus.
Ticket Monster, Inc.
Willkie represented Ticket Monster, South Korea’s top social commerce site, in its sale to U.S.-based LivingSocial. (2011)